疾患タンパク質分解薬の効果を促進する原理の解明

• Project/Area Number: 25K22531
• Research Category: Grant-in-Aid for Challenging Research (Exploratory)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 47:Pharmaceutical sciences and related fields
• Research Institution: Hoshi University
• Principal Investigator: 大竹 史明 星薬科大学, 先端生命科学研究所, 准教授 (60447373)
• Project Period (FY): 2025-06-27 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2027: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000); Fiscal Year 2026: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000); Fiscal Year 2025: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)